Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

As the year begins under a new Trump Administration, healthcare providers and private equity firms should consider the antitrust ...

Sysco allows restaurants to buy the bulk of its needs from a single source rather than dozens of producers, simplifying logistics and saving time. While the goods it sells are commodities, Sysco can ...

In March 2024, the Federal Trade Commission (FTC), the Department of Justice (DOJ) and the Department of Health and Human Services ...

Sen. Elizabeth Warren (D-Mass.) sent tech billionaire Elon Musk 30 ideas for how the newly formed Department of Government Efficiency (DOGE) could cut government spending. Warren’s Thursday letter to ...

The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, easily outpacing consumption growth and fueling ...

As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...